The head of the maker of remdesivir, an anti-viral shown to reduce recovery times in COVID-19 patients, said Sunday the company has been exporting the drug and is making it available to patients in the United States through the US government. Gilead Sciences CEO Daniel O'Day said the company is donating its entire existing supply of the drug -- 1.5 million vials, enough to treat 100,000 to 200,000 patients. "And our collaboration with the government has been such, we have been very transparent with them here in the United States and we have a good relationship on future allocation."
from Yahoo News - Latest News & Headlines https://news.yahoo.com/gilead-sciences-exporting-remdesivir-ceo-says-180558527.html
إرسال تعليق